For instance, in aggressive MCL, MCL-1 inhibition, both alone or together with venetoclax, ibrutinib, or BCL-xL inhibition synergistically induced apoptosis and effectively eradicated lymphoma cells protected by the microenvironment101. Here, BCL2L1 is linked to mantle cell lymphoma.